Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-104
Closed -$8.39K 693
2023
Q1
$8.39K Buy
104
+36
+53% +$2.9K 0.01% 260
2022
Q4
$5.09K Buy
68
+3
+5% +$214 ﹤0.01% 427
2022
Q3
$4K Sell
65
-16
-20% -$1.11K ﹤0.01% 489
2022
Q2
$6K Buy
81
+43
+113% +$3.19K 0.01% 293
2022
Q1
$3K Buy
38
+4
+12% +$288 ﹤0.01% 278
2021
Q4
$3K Buy
+34
New +$2.5K ﹤0.01% 228

Other funds holding HOLX

Schubert & Co's HOLX Position: Q2 2023 in Review

Schubert & Co sold out of Hologic (HOLX) in Q2 2023, closing a stake of 104 shares — an estimated $8.39K sold.

Schubert & Co first reported a position in HOLX in Q4 2021 and held it in 6 quarters. The position peaked at $8.39K in Q1 2023. 713 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • Schubert & Co reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 104 Hologic shares in Q2 2023, an estimated $8.39K.
  • Schubert & Co first reported a position in Hologic in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Hologic position peaked at $8.39K in Q1 2023.
  • 713 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.